drugset / Trial / NCT06852638
CD70-targeted immunoPET Imaging of Malignant Cancers
NaSingle-groupOpen-labelDiagnostic
Summary
This study aims to determine the value of cluster of differentiation (CD70)-targeted immuno-positron emission tomography/computed tomography (immunoPET/CT) imaging for diagnosing human malignancies, including renal cell carcinoma (particularly clear cell renal cell carcinoma), lymphoma, and nasopharyngeal carcinoma (NPC), among others.
Timeline
- Start
- 2024-12-23
- Primary completion
- 2026-12-23
- Completion
- 2026-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]F-RESCA-R8B4 | Diagnostic / imaging agent | 0.37 mbq/kg | Other |
| Subject | [18F]F-RESCA-R8B4 | Diagnostic / imaging agent | 3.7 mbq/kg | Other |
| Subject | [18F]F-RESCA-RCCB6 | Diagnostic / imaging agent | 0.37 mbq/kg | Other |
| Subject | [18F]F-RESCA-RCCB6 | Diagnostic / imaging agent | 3.7 mbq/kg | Other |
| Subject | [18F]F-RESCA-RD06 | Diagnostic / imaging agent | 0.37 mbq/kg | Other |
| Subject | [18F]F-RESCA-RD06 | Diagnostic / imaging agent | 3.7 mbq/kg | Other |
| Subject | [68Ga]Ga-NOTA-R8B4 | Diagnostic / imaging agent | 0.37 mbq/kg | Other |
| Subject | [68Ga]Ga-NOTA-R8B4 | Diagnostic / imaging agent | 3.7 mbq/kg | Other |
| Subject | [68Ga]Ga-NOTA-RD06 | Diagnostic / imaging agent | 0.37 mbq/kg | Other |
| Subject | [68Ga]Ga-NOTA-RD06 | Diagnostic / imaging agent | 3.7 mbq/kg | Other |